Healthcare -
Biotechnology - NASDAQ - US
$ 4.41
-2.65 %
$ 204 M
Market Cap
-1.55
P/E
FDMT - NET CHANGE IN CASH
Net Change in Cash FDMT - 4D Molecular Therapeutics, Inc.
197 M
LAST VALUE
89.48%
2 YEAR CAGR
23.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR